Inhibition of BMI1 induces autophagy-mediated necroptosis

Anindya Dey, Soumyajit Banerjee Mustafi, Sounik Saha, Shailendra Kumar Dhar Dwivedi, Priyabrata Mukherjee, Resham Bhattacharya

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

ABSTRACT: The clonal self-renewal property conferred by BMI1 is instrumental in maintenance of not only normal stem cells but also cancer-initiating cells from several different malignancies that represent a major challenge to chemotherapy. Realizing the immense pathological significance, PTC-209, a small molecule inhibitor of BMI1 transcription has recently been described. While targeting BMI1 in various systems significantly decreases clonal growth, the mechanisms differ, are context-dependent, and somewhat unclear. We report here that genetic or pharmacological inhibition of BMI1 significantly impacts clonal growth without altering CDKN2A/INK4/ARF or CCNG2 and induces autophagy in ovarian cancer (OvCa) cells through ATP depletion. While autophagy can promote survival or induce cell death, targeting BMI1 engages the PINK1-PARK2-dependent mitochondrial pathway and induces a novel mode of nonapoptotic, necroptosis-mediated cell death. In OvCa, necroptosis is potentiated by activation of the RIPK1-RIPK3 complex that phosphorylates its downstream substrate, MLKL. Importantly, genetic or pharmacological inhibitors of autophagy or RIPK3 rescue clonal growth in BMI1 depleted cells. Thus, we have established a novel molecular link between BMI1, clonal growth, autophagy and necroptosis. In chemoresistant OvCa where apoptotic pathways are frequently impaired, necroptotic cell death modalities provide an important alternate strategy that leverage overexpression of BMI1.

Original languageEnglish (US)
Pages (from-to)659-670
Number of pages12
JournalAutophagy
Volume12
Issue number4
DOIs
StatePublished - Apr 2 2016
Externally publishedYes

Fingerprint

Autophagy
Ovarian Neoplasms
Cell Death
Growth
Pharmacology
Neoplastic Stem Cells
Adenosine Triphosphate
Maintenance
Drug Therapy
Neoplasms

Keywords

  • autophagy
  • BMI1
  • necroptosis
  • ovarian cancer
  • PTC-209

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Dey, A., Mustafi, S. B., Saha, S., Kumar Dhar Dwivedi, S., Mukherjee, P., & Bhattacharya, R. (2016). Inhibition of BMI1 induces autophagy-mediated necroptosis. Autophagy, 12(4), 659-670. https://doi.org/10.1080/15548627.2016.1147670

Inhibition of BMI1 induces autophagy-mediated necroptosis. / Dey, Anindya; Mustafi, Soumyajit Banerjee; Saha, Sounik; Kumar Dhar Dwivedi, Shailendra; Mukherjee, Priyabrata; Bhattacharya, Resham.

In: Autophagy, Vol. 12, No. 4, 02.04.2016, p. 659-670.

Research output: Contribution to journalArticle

Dey, A, Mustafi, SB, Saha, S, Kumar Dhar Dwivedi, S, Mukherjee, P & Bhattacharya, R 2016, 'Inhibition of BMI1 induces autophagy-mediated necroptosis', Autophagy, vol. 12, no. 4, pp. 659-670. https://doi.org/10.1080/15548627.2016.1147670
Dey A, Mustafi SB, Saha S, Kumar Dhar Dwivedi S, Mukherjee P, Bhattacharya R. Inhibition of BMI1 induces autophagy-mediated necroptosis. Autophagy. 2016 Apr 2;12(4):659-670. https://doi.org/10.1080/15548627.2016.1147670
Dey, Anindya ; Mustafi, Soumyajit Banerjee ; Saha, Sounik ; Kumar Dhar Dwivedi, Shailendra ; Mukherjee, Priyabrata ; Bhattacharya, Resham. / Inhibition of BMI1 induces autophagy-mediated necroptosis. In: Autophagy. 2016 ; Vol. 12, No. 4. pp. 659-670.
@article{8c2cb0a999cd465b9d6191df9bb3fbeb,
title = "Inhibition of BMI1 induces autophagy-mediated necroptosis",
abstract = "ABSTRACT: The clonal self-renewal property conferred by BMI1 is instrumental in maintenance of not only normal stem cells but also cancer-initiating cells from several different malignancies that represent a major challenge to chemotherapy. Realizing the immense pathological significance, PTC-209, a small molecule inhibitor of BMI1 transcription has recently been described. While targeting BMI1 in various systems significantly decreases clonal growth, the mechanisms differ, are context-dependent, and somewhat unclear. We report here that genetic or pharmacological inhibition of BMI1 significantly impacts clonal growth without altering CDKN2A/INK4/ARF or CCNG2 and induces autophagy in ovarian cancer (OvCa) cells through ATP depletion. While autophagy can promote survival or induce cell death, targeting BMI1 engages the PINK1-PARK2-dependent mitochondrial pathway and induces a novel mode of nonapoptotic, necroptosis-mediated cell death. In OvCa, necroptosis is potentiated by activation of the RIPK1-RIPK3 complex that phosphorylates its downstream substrate, MLKL. Importantly, genetic or pharmacological inhibitors of autophagy or RIPK3 rescue clonal growth in BMI1 depleted cells. Thus, we have established a novel molecular link between BMI1, clonal growth, autophagy and necroptosis. In chemoresistant OvCa where apoptotic pathways are frequently impaired, necroptotic cell death modalities provide an important alternate strategy that leverage overexpression of BMI1.",
keywords = "autophagy, BMI1, necroptosis, ovarian cancer, PTC-209",
author = "Anindya Dey and Mustafi, {Soumyajit Banerjee} and Sounik Saha and {Kumar Dhar Dwivedi}, Shailendra and Priyabrata Mukherjee and Resham Bhattacharya",
year = "2016",
month = "4",
day = "2",
doi = "10.1080/15548627.2016.1147670",
language = "English (US)",
volume = "12",
pages = "659--670",
journal = "Autophagy",
issn = "1554-8627",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - Inhibition of BMI1 induces autophagy-mediated necroptosis

AU - Dey, Anindya

AU - Mustafi, Soumyajit Banerjee

AU - Saha, Sounik

AU - Kumar Dhar Dwivedi, Shailendra

AU - Mukherjee, Priyabrata

AU - Bhattacharya, Resham

PY - 2016/4/2

Y1 - 2016/4/2

N2 - ABSTRACT: The clonal self-renewal property conferred by BMI1 is instrumental in maintenance of not only normal stem cells but also cancer-initiating cells from several different malignancies that represent a major challenge to chemotherapy. Realizing the immense pathological significance, PTC-209, a small molecule inhibitor of BMI1 transcription has recently been described. While targeting BMI1 in various systems significantly decreases clonal growth, the mechanisms differ, are context-dependent, and somewhat unclear. We report here that genetic or pharmacological inhibition of BMI1 significantly impacts clonal growth without altering CDKN2A/INK4/ARF or CCNG2 and induces autophagy in ovarian cancer (OvCa) cells through ATP depletion. While autophagy can promote survival or induce cell death, targeting BMI1 engages the PINK1-PARK2-dependent mitochondrial pathway and induces a novel mode of nonapoptotic, necroptosis-mediated cell death. In OvCa, necroptosis is potentiated by activation of the RIPK1-RIPK3 complex that phosphorylates its downstream substrate, MLKL. Importantly, genetic or pharmacological inhibitors of autophagy or RIPK3 rescue clonal growth in BMI1 depleted cells. Thus, we have established a novel molecular link between BMI1, clonal growth, autophagy and necroptosis. In chemoresistant OvCa where apoptotic pathways are frequently impaired, necroptotic cell death modalities provide an important alternate strategy that leverage overexpression of BMI1.

AB - ABSTRACT: The clonal self-renewal property conferred by BMI1 is instrumental in maintenance of not only normal stem cells but also cancer-initiating cells from several different malignancies that represent a major challenge to chemotherapy. Realizing the immense pathological significance, PTC-209, a small molecule inhibitor of BMI1 transcription has recently been described. While targeting BMI1 in various systems significantly decreases clonal growth, the mechanisms differ, are context-dependent, and somewhat unclear. We report here that genetic or pharmacological inhibition of BMI1 significantly impacts clonal growth without altering CDKN2A/INK4/ARF or CCNG2 and induces autophagy in ovarian cancer (OvCa) cells through ATP depletion. While autophagy can promote survival or induce cell death, targeting BMI1 engages the PINK1-PARK2-dependent mitochondrial pathway and induces a novel mode of nonapoptotic, necroptosis-mediated cell death. In OvCa, necroptosis is potentiated by activation of the RIPK1-RIPK3 complex that phosphorylates its downstream substrate, MLKL. Importantly, genetic or pharmacological inhibitors of autophagy or RIPK3 rescue clonal growth in BMI1 depleted cells. Thus, we have established a novel molecular link between BMI1, clonal growth, autophagy and necroptosis. In chemoresistant OvCa where apoptotic pathways are frequently impaired, necroptotic cell death modalities provide an important alternate strategy that leverage overexpression of BMI1.

KW - autophagy

KW - BMI1

KW - necroptosis

KW - ovarian cancer

KW - PTC-209

UR - http://www.scopus.com/inward/record.url?scp=84964417430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964417430&partnerID=8YFLogxK

U2 - 10.1080/15548627.2016.1147670

DO - 10.1080/15548627.2016.1147670

M3 - Article

VL - 12

SP - 659

EP - 670

JO - Autophagy

JF - Autophagy

SN - 1554-8627

IS - 4

ER -